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The results of 3 experiments examining the influence of estrogen on the nigrostriatal dopamine (DA) system are reported. In 
two experiments the influence of hormonal manipulations on amphetamine (AMPH)-induced rotational behavior was investi- 
gated using rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. It was found that: (1)female rats in estrus 
make more rotations than ovariectomized (OVX) rats; and (2) estrogen treatment (5/~g estradiol benzoate, daily for 4 days) 
in OVX rats enhances AMPH-induced rotational behavior 4 h and 4 days after estrogen treatment. During the intervening 
period, at 24 h after cessation of estrogen treatment, control and hormone-treated animals did not differ. In a third experiment, 
the effect of estrogen treatment on the release of endogenous DA from striatal tissue slices in superfusion was examined. Estrogen 
enhanced AMPH-stimulated striatal DA release 4 h after the last treatment relative to OVX controls. However, 24 h and 4 days 
after estrogen treatment DA release had returned to control levels. It is suggested that estrogen has an immediate potentiating 
effect on striatal DA release, and this may be responsible for the increased behavioral response to AMPH 4 h after estrogen 
treatment. The previously demonstrated increase in postsynaptic striatal DA receptors may be responsible for the second 
increase in AMPH-induced rotational behavior, that occurs 4 days after estrogen treatment. 
INTRODUCTION 
Estrogen is known to influence neuronal activi- 
ty in the hypothalamus and thereby exert 
feedback control over reproductive functions and 
sexual behavior ~5,26,28. However, many non- 
reproductive behaviors are also modulated by es- 
trogen 3, suggesting that estrogen may influence 
neural activity in extrahypothalamic brain 
regions. For example, a number of researchers 
have suggested that estrogen influences activity in 
the nigrostriatal dopamine (DA) system ~7,2~. 
We have previously reported that there are 
estrous cycle dependent variations in amphe- 
tamine (AMPH)-stimulated striatal DA release 
in vitro and rotational behavior 4"7"3°. On estrus, 
6-12 h after the endogenous hormonal surges, 
rotational behavior and AMPH-stimulated stria- 
tal DA release both increase relative to other days 
of the estrous cycle. The removal of the endo- 
genous source of gonadal steroids by ovariectomy 
(OVX) attenuates AMPH-stimulated striatal DA 
release and electrical stimulation-induced ro- 
tational behavior 4'3°. In addition, the treatment of 
OVX rats with estrogen plus progesterone results 
in an increase in striatal DA release stimulated by 
either AMPH or potassium 4'5. However, estrogen 
treatment alone in OVX rats has no effect on 
AMPH-stimulated striatal DA release measured 
24 h later 4. 
Interestingly, the effect of estrogen on the ni- 
grostriatal DA system appears to be closely asso- 
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ciated with the interval between hormone treat- 
ment and the subsequent behavioral or 
neurochemical test 17'18'a°. In general, 24 h after 
estrogen, behavioral indices of striatal DA activity 
are attenuated, whereas 2-6  days later these same 
behaviors are potentiated. Therefore, it is possible 
that estrogen treatment influences striatal DA 
release at time points other than the one con- 
sidered in our previous study 4. In the series of 
experiments reported here, we examine the effect 
of OVX on AMPH-induced rotational behavior 
as well as the influence of estrogen on striatal DA 
release and rotational behavior at 3 time points: 
4 h, 24 h and 4 days after estrogen treatment. We 
hypothesize that estrogen-induced changes in 
striatal DA release participate in the immediate 
effect of estrogen on the nigrostriatal DA system. 
Behavioral and neurochemical data in support of 
this idea are reported. 
MATERIALS AND METHODS 
Adult female rats (Holtzman, Madison, WI) 
were maintained on a reversed light:dark cycle 
(14: 10, lights offat  08.00 h) with food and water 
freely available. All treatments and procedures 
were conducted between 10.00 h and 14.00 h in 
order to minimize diurnal variation. 
Experiment 1 
The influence of  ovariectomy on AMPH-induced 
rotational behavior. Animals were pretreated with 
desipramine (25 mg/kg) to protect noradrenergic 
neurons 9, then anesthetized with chloropent 
(2.4ml/kg; Fort Dodge Laboratories, Fort 
Dodge, IA) supplemented by metofane (by inhala- 
tion; Pitman-Moore, Washington Crossing, N J). 
Animals were positioned in a stereotaxic instru- 
ment and 8 #g 6-hydroxydopamine hydrobromide 
(6-OHDA) in 4 #1 normal saline (also containing 
0.19/0 ascorbic acid) was infused into the right 
substantia nigra at a rate of 1 #l/min. Two weeks 
later, half of the animals were ovariectomized 
(OVX, n = 21) under ether anesthesia. The other 
half of the animals received a sham operation 
(INTACT, n = 21). After an additional 2 weeks 
for recovery, OVX rats received daily injections 
of 0.1 ml peanut oil (s.c.) for 8 consecutive days. 
INTACT females were monitored for at least 2 
consecutive estrous cycles (8-10 days) by daily 
examination of the vaginal epithelium and were 
tested on the day of estrus. 
Approximately 5 weeks after the 6-OHDA 
lesions, INTACT females in estrus and OVX 
animals were tested for AMPH-induced rota- 
tional behavior in automated rotometers 3~. After 
a 15-min habituation period, the animals were 
given an i.p. injection of D-AMPH sulfate. Testing 
occurred under standard white light illumination. 
Some animals from each group (OVX, n = 9; 
INTACT, n = 8) received 0.65 mg/kg AMPH 
and rotational behavior was recorded for 90 min. 
The other animals in each group (OVX, n = 12; 
Intact, n = 13) received 2.5 mg/kg AMPH and 
rotational behavior was recorded for 120 min. 
Rotations were cumulated over 5 min intervals 
and a rotation was defined as 4 consecutive 90 ° 
in the same direction. Three weeks later the ani- 
mals were tested a second time, either on the day 
of estrus or after treatments with oil. Rotational 
behavior was measured as just described, except 
that all animals received 2.5 mg/kg and rotational 
behavior was recorded for 120 min. Statistical 
evaluation of the differences between groups were 
conducted by two-way analysis of variance 
(group x time). 
At the conclusion of the experiment, the ani- 
mals were killed by decapitation and striatal DA 
concentrations were determined by high perform- 
ance liquid chromatography with electrochemical 
detection (HPLC-EC) after extraction ofcatecho- 
lamines with alumina adsorbent 3~. Only the 
results from animals with > 90~  DA depletion 
were included in the analysis so as to reduce 
variability in AMPH-induced rotational behavior 
that is associated with partial lesions. 
Experiment 2 
The influence of estrogen treatment on AMPH- 
induced rotational behavior in O VX rats. Animals 
received 6-OHDA lesions of the fight substantia 
nigra and were OVX 2 weeks later as described in 
Expt. 1. After an additional 2-week recovery 
period, a hormone treatment regimen began in 
which each animal received 8 s.c. injections. The 
hormone treatment groups received estradiol 
benzoate (EB; 5 #g in 0.1 ml peanut oil) on 4 
consecutive days and vehicle (0.1 ml peanut oil) 
on the other 4 days. The protocol for hormone 
administration was designed to approximate the 
4-day estrous cycle of the female rat. The length 
of the time after EB was varied. The E B : 4 D  
group (n = 16) received EB for 4 days and was 
tested 4 days later (oil for 4 days). The EB : 24H 
group (n = 15) was tested 24 h after EB. The 
EB : 4H group was tested 4 h after EB (n = 14). 
A control group (OVX(OIL), n - -  12) received 
injections ofoil on 8 consecutive days. This group 
also served as one of the OVX(OIL) groups in 
Expt. 1. Four h after the last oil or EB treatment, 
animals were given 2.5 mg/kg AMPH and rota- 
tional behavior was measured for 120 min as 
described in Expt. 1. At the conclusion of the 
experiment, DA concentrations in the striatum 
were determined by HPLC-EC; only the results 
from animals with >90~o DA depletion were 
included in the statistical analysis. 
Experiment 3 
The influence of  estrogen on AMPH-stimulated 
release of  endogenous DA in vitro. Female rats were 
ovarectomized under ether anesthesia and allow- 
ed to recover for two weeks. Animals were then 
assigned to 1 of 4 treatment groups (n -- 5/group). 
The groups were: EB : 4D, EB : 24H, EB : 4H, 
and OVX(OIL), as just described for Expt. 2. 
Four h after the last oil or hormone treatment, the 
animals were killed by decapitation. The striata 
were rapidly dissected, and 1 - m m  3 t i s s u e  f r a g -  
m e n t s  were placed in superfusion chambers with 
a volume of 200 #1 containing a Krebs-Ringer 
phosphate medium, pH 7.4, maintained at 37 °C 
in a water-bath 6. Medium continuously flowed 
through the chamber at a rate of 100 #l/min. 
Following a 75-min stabilization period, 
effluent samples were collected at 5-min intervals. 
The amount of endogenous DA released into the 
medium was measured in the effluent samples by 
HPLC-EC 6. The first sample was collected to 
determine basal DA efflux, the medium con- 
taining 10 #M D-AMPH was infused for 2.5 min 
and 4 additional samples were collected to deter- 
mine AMPH-stimulated DA release. This dose of 
AMPH was determined to produce consistant, 
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but less than the maximum, DA release in dose- 
response studies 6. The amount of DA in each 




Ovariectomy attenuates AMPH-induced rota- 
tional behavior. Table I shows that OVX rats 
made significantly fewer rotations than intact fe- 
male rats with either dose of AMPH. This was 
true during both the first and the second test 
sessions. Both groups made more rotations dur- 
ing the second test session than during the first, 
as previously reported 31. 
Experiment 2 
Time course of  the effect of  estrogen on AMPH- 
induced rotational behavior. Estrogen treatment 
had both immediate and long-term effects on 
AMPH-induced rotational behavior. In a two- 
way analysis of variance (group x time), there 
was a significant effect of  treatment group on the 
number of rotations produced during the 2-h test 
period (F3.53 = 2.81, P <  0.05). The EB :4H 
group made significantly more rotations 
TABLE I 
The influence o f  ovariectomy on AMPH-induced rotational 
behavior 
Group (n) Dose of  A M P H  1 Total rotations 2 
INTACT (8) 0.653 220 + 26* 
OVX (9) 0.653 137 + 16 
INTACT (13) 2.53 628 + 93** 
OVX (12) 2.53 422 _+ 78 
INTACT (21) 2.54 1041 + 90*** 
OVX (21) 2.54 729 + 85 
1Dose of A M P H  in mg/kg. Rotational behavior was 
recorded for 90 min after a dose of 0.65 mg/kg and 2 h after 
2.5mg/kg; 2 m e a n +  S.E.M.; 3first AMPH treatment;  
4 second AMPH treatment;  * INTACT > OVX: 
F t :  5 = 7.98, P = 0.012; ** INTACT females exhibit a more 
rapid onset of rotational behavior than do OVX females, 
resulting in a significant interaction between groups: 
Fll,253 = 2.0, P < 0.03; *** INTACT > OVX: FI ,49  --- 5.41, 
P < 0.025. 
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throughout the 2-h test period than did 
OVX(OIL) controls (P < 0.05, Fig. 1A). There 
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EB:4H EB:24H EB~4D 
Fig. 1. The influence of estrogen treatment on AMPH- 
induced rotational behavior. OVX rats with unilateral 
6-OHDA lesions of the substantia nigra were treated with 
5/~gEB for 4days  and tested for 4 h  (EB:4H) ,  2 4 h  
(EB : 24H) or 4 days (EB : 4D) later. Control animals 
received oil injections (OVX(OIL)). Rotational behavior was 
measured for 2 h following the administration of 2.5 mg/kg 
AMPH. A: time course of the behavioral response. Total 
rotations were cumulated over 5-min intervals for the 
OVX(OIL) group (n = 12, solid line) and the EB : 4H group 
(n = 14, dashed line). There was a significant effect of 
hormone treatment on rotational behavior throughout the 
2-h testing session (F3,53 = 2.808, P = 0.047). In subsequent 
pairwise comparisons the E B : 4 H  group made significantly 
more net rotations than did the OVX(OIL) control group 
(P < 0.05). The profile of the time course of the behavioral 
response to AMPH in the EB : 4D group was comparable to 
that  seen in the EB :4H group. B: total rotations cumulated 
over 120 min. There was a significant effect of hormone 
treatment  on the total number of rotations made during the 
behavioral testing session (F3.53 = 2.834, P = 0.046). Total 
rotations for each group (mean + S.E.M.): OVX, 422 + 78; 
E B : 4 H ,  6 0 9 + 9 3 ;  EB:24H,  432_+42; and E B : 4 D ,  
672 _+ 77. *AMPH-induced rotational behavior was signifi- 
cantly greater at 4 h and 4 days after estrogen treatment than 
in OVX(OIL) animals (P < 0.05). 
treated animals 24 h after hormone treatment. 
However, 4 days after EB treatment animals exhi- 
bited enhanced AMPH-induced rotational be- 
havior once again (P < 0.05, Fig. 1B). 
Experiment 3 
Time course of  the effect of estrogen on AMPH- 
stimulated striatal DA release. There was also a 
significant effect of estrogen treatment on the 
AMPH-stimulated release of endogenous DA 
from striatal tissue fragments in vitro (two-way 
ANOVA, group x time (i.e. 5 collection inter- 
vals), significant interaction: F12,64 = 2.362, P = 
0.013; Fig. 2). The AMPH-stimulated increase in 
DA release was significantly greater 4 h after EB 
than was found with striatal tissue obtained from 
any of the other 3 groups (P < 0.05). With striatal 
tissue from the EB:24H,  E B : 4 D  or the 
OVX(OIL) groups, the AMPH-stimulated re- 
lease of DA had already begun to decline by the 
time of the third collection interval. In contrast, 
the AMPH-stimulated release of DA was sus- 
tained through the third interval with striatal 
tissue from the EB : 4H group (Fig. 2B). 
DISCUSSION 
The experiments reported here demonstrate 
that OVX attenuates AMPH-induced rotational 
behavior in the female rat. This result was pre- 
dicted, since OVX has been shown to attenuate 
AMPH-stimulated striatal DA release as well as 
rotational behavior induced by electrical stimula- 
tion of the nigrostriatal bundle 4,3°. Estrogen treat- 
ment restored the behavioral response to AMPH 
at two time points, immediately following (4 h) the 
cessation of estrogen treatment and again 4 days 
later. Interposed between these 2periods of 
heightened behavioral responsiveness to AMPH, 
is a period 24 h after estrogen treatment, when 
control and hormone-treated animals did not 
differ in rotational behavior. We found no evi- 
dence for an attenuation of striatal DA release or 
AMPH-induced rotational behavior 24 h after 
hormone treatment as might be expected from 
previous reports 8''7. In addition, the AMPH-sti- 
mulated release of DA from striatal tissue was 
potentiated relative to OVX(OIL) 4 h after estro- 
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Fig. 2. The influence of estrogen on AMPH-stimulated stria- 
tal DA release. The release of endogenous DA from striatal 
tissue slices in a superfusion system was examined following 
hormonal manipulations. Female rats were OVX and then 
treated with EB as described in the legend to Fig. 1 and the 
text. After the first 5 min effluent sample was collected, 
10 #m AMPH (in medium) was infused for 2.5 min and 
samples were collected at 5-min intervals for an additional 
20 min (intervals 2-5). A: time course of AMPH-stimulated 
striatal DA release. There was significantly more (P < 0.05) 
AMPH-stimulated DA release from striatal tissue obtained 
4 h after estrogen withdrawal (EB:4H,  dashed line) than 
from control animals (OVX(OIL), solid line). This difference 
is due to a more sustained release of DA in the EB : 4H group. 
The bar marks the interval when AMPH was introduced into 
the superfusion chamber; * interval depicted for all groups in 
Fig. 2B. B: the influence of estrogen on AMPH-stimulated 
striatal DA release. There was significantly more AMPH- 
stimulated DA release from striatal tissue obtained from the 
EB : 4H group, during the third interval (second post-AMPH 
interval, marked with • in Fig. 2A) than for any other group 
(P < 0.05). Bars indicated + S.E.M. 
gen treatment, but not at any other time point 
tested. 
The t'mding that rotational behavior is in- 
creased at both 4 h and 4 days after estrogen 
treatment, while AMPH-stimulated DA release is 
31 
greater only 4 h after estrogen, suggests that there 
is more than one component contributing to the 
effect of estrogen on nigrostriatal DA activity. 
The results presented here suggest that the initial 
effect of estrogen is to potentiate the stimulated 
release of striatal DA. How estrogen enhances 
AMPH-stimulated striatal DA release and ro- 
tational behavior is not known, but the available 
evidence suggests the following possibility. 
AMPH is thought to release DA from a nonvesi- 
cular, storage pool by exchange diffusion, a pro- 
cess mediated by the DA reuptake carrier 16. Ac- 
tivity of the reuptake carrier is sensitive to Na + 
and K + concentrations and may be further regu- 
lated by membrane polarity 16,24. The AMPH-sti- 
mulated release of DA should be similarly regu- 
lated. (The transport of glutamate and serotonin 
in brain and catecholamines in adrenal chro- 
maffin cells have been shown to be electrogenic 24. 
Whether DA transport in the striatum is similarly 
modulated by membrane polarity has not been 
tested directly.) Low-frequency stimulation of the 
nigrostriatal pathway results in decreased termi- 
nal excitability and presumably hyperpolari- 
z a t i o n  33. AMPH-stimulated [3H]DA release is 
greater during low-frequency stimulation of the 
nigrostriatal pathway than the sum of release in- 
duced by either AMPH or electrical stimuation 
alone 34. Therefore, one possible mechanism of 
estrogen's action in the nigrostriatal DA system is 
to enhance AMPH-stimulated DA release by hy- 
perpolarizing striatal DA terminals. 
Evidence to support the idea that estrogen 
treatment is associated with hyperpolarization in 
nigrostriatal DA neurons comes from electro- 
physiological studies. Estrogen treatment is fol- 
lowed by a decrease in spontaneous activity in 
nigral DA neurons 1°,~ and an increase in spon- 
taneous activity in striatal DA-sensitive neurons 2. 
The effect of estrogen in the nigra occurs within 
minutes following estrogen administration (i.v.)~ '. 
Interestingly, the effect of estrogen in the nigra 
is similar to the effect of DA agonists and is 
reversed by treatment with the DA antagonist 
haloperidol ]|. DA agonists are known to decrease 
spontaneous activity both in nigral DA cell bodies 
and in DA terminals in the caudate by hyper- 
polarizing DA neurons ~'11.19.32. Therefore, hyper- 
32 
polarization in DA neurons occurs in association 
with the DA agonist-induced increase in activity 
in the nigrostriatal DA system. The finding that 
estrogen has an effect similar to DA agonists on 
electrical activity in both the nigra and striatum 
suggests that estrogen also potentiates activity in 
the nigrostriatal DA system. 
The estrogen-induced potentiation of striatal 
DA activity may mediate both the increase in 
AMPH-stimulated DA release at 4 h (by the me- 
chanism proposed above) and the increase in 
AMPH-stimulated rotational behavior that oc- 
curs 4 days after EB. For example, potentiation of 
the striatal DA system by DA agonists has been 
shown to induce changes in DA receptors. The 
sensitivity of DA autoreceptors is decreased 24 h 
after AMPH 35 and there is a behavioral hypo- 
sensitivity to APO after prior APO pretreat- 
ment 25. In addition, 3-5 days after pretreatment 
with APO or AMPH,  APO-induced stereotypy 
and rotational behavior are enhanced and there is 
an increase in the number of striatal DA recep- 
tors ~2-~4. The effect of estrogen on striatal DA 
neurons may be analagous to the effect of DA 
agonists and it may also trigger compensatory 
postsynaptic responses including: (1) a decrease 
in the behavioral response to DA receptor agon- 
ists, 24 h after estrogen treatment i ~,17.18.22,29; and 
(2) an increase in dopamine mediated behaviors 
and in the number of striatal DA receptors 
2-6  days later ~s'2~. 
Whether there is a direct effect of estrogen on 
nigrostriatal DA neurons is yet to be conclusively 
determined. However, direct effects of 17-fl- 
estradiol in the striatum on APO-induced postur- 
al deviation has been reported 23. Unilateral im- 
plants of crystalline estradiol result in postural 
deviation ipsilateral to the implant when low 
doses (0.07 or 0.75 mg/kg) of APO are adminis- 
tered, but not with a higher dose (3 mg/kg). Since 
low doses of APO are thought to act selectively at 
inhibitory DA autoreceptors and higher doses are 
thought to stimulate postsynaptic DA receptors ~, 
this finding suggests that there is a direct effect of 
estrogen on presynaptic DA activity and a com- 
plex interaction between the presynaptic effects of 
APO and estrogen. 
An effect of estrogen on nigrostriatal DA activi- 
ty may be responsible for some of the estrous 
cycle-dependent variation in non-reproductive 
behaviors in the female rodent as well. For ex- 
ample, there is an increase in locomotor activity, 
exploratory behavior, running wheel activity and 
sensory responsiveness on estrus or following es- 
trogen treatment 3. In summary, the data pre- 
sented here indicate that the immediate effect of 
estrogen on the striatum is to enhance striatal DA 
release, thereby enhancing sensori-motor respon- 
siveness. 
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